BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33906873)

  • 1. Sarcomatoid urothelial carcinoma of the bladder with osseous metaplasia: bone in urinary bladder.
    Varshney B; Choudhary GR; Yadav T; Nalwa A
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33906873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal osseous metaplasia in urothelial carcinoma of the bladder: An unusual and challenging feature. A case report.
    Iglesias de Ussel Galarreta I; Queipo Gutiérrez FJ
    Rev Esp Patol; 2024; 57(2):116-119. PubMed ID: 38599730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomatoid carcinoma with osseous differentiation in the bladder.
    Arenas LF; Fontes DA; Pereira EM; Hering FL
    Int Braz J Urol; 2006; 32(5):563-5. PubMed ID: 17081326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
    Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
    World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report.
    Kamei M; Shinohara T; Kasahara K; Kuno T; Naruse K; Watanabe H
    J Med Case Rep; 2015 Sep; 9():199. PubMed ID: 26358638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
    Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
    Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of transitional cell carcinoma of the urinary bladder at Kenyatta National Hospital, Nairobi.
    Waihenya CG; Mungai PN
    East Afr Med J; 2006 Dec; 83(12):679-83. PubMed ID: 17685214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sarcomatoid carcinoma of the bladder with major osseous metaplasia].
    Gazaigne J; Mozziconacci JG; Provendier B; Sebe P
    Prog Urol; 1998 Dec; 8(6):1051-3. PubMed ID: 9894268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcomatoid Urothelial Carcinoma of the Urinary Bladder With Chondrosarcomatous and Concurrent Divergent Squamous Cell Carcinoma Differentiation- A Rare Entity.
    Kumar Pal A; Srinivas BH; Kalra S; Dorairajan LN; Sreenivasan Kodakkattil S
    Cureus; 2022 Dec; 14(12):e33107. PubMed ID: 36721592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma of the bladder: a case report.
    Oka T; Matsuzaki K; Izumi H; Nonomura D; Mori K; Nishimura K
    J Med Case Rep; 2022 Mar; 16(1):118. PubMed ID: 35331306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcomatoid urothelial bladder carcinoma in adults: Histology, symptomatology, treatments and survival.
    Sabaté Arroyo XA; Rodrigo Lara H; Carrillo García P; Brugarolas Rosselló J; Pizá Reus P
    Actas Urol Esp (Engl Ed); 2019 Mar; 43(2):106-110. PubMed ID: 30287139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal osseous metaplasia in urothelial carcinoma of the bladder: a rare case report and literature review.
    Razafimahefa J; Gosset C; Mongiat-Artus P; Andriamampionona TF; Verine J
    Diagn Pathol; 2019 Jul; 14(1):75. PubMed ID: 31299983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.
    Supit W; Mochtar CA; Santoso RB; Umbas R
    Asian J Surg; 2014 Oct; 37(4):184-9. PubMed ID: 24637186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
    Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
    World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection and gemcitabine/cisplatin combination positively effect survival in sarcomatoid carcinoma of the urinary bladder.
    Başeskioglu B; Duman BB; Kara IO; Can C; Yildirim M; Açikalin M
    Asian Pac J Cancer Prev; 2012; 13(11):5729-33. PubMed ID: 23317247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guérin treatment of urothelial carcinoma arising in the ileal neobladder after radical cystectomy.
    Yamashita R; Matsuzaki M; Niwakawa M; Ito I
    Int J Urol; 2014 Mar; 21(3):333-4. PubMed ID: 23991753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy.
    Thomas DE; Kaimakliotis HZ; Rice KR; Pereira JA; Johnston P; Moore ML; Reed A; Cregar DM; Franklin C; Loman RL; Koch MO; Bihrle R; Foster RS; Masterson TA; Gardner TA; Sundaram CP; Powell CR; Beck SDW; Grignon DJ; Cheng L; Albany C; Hahn NM
    Clin Genitourin Cancer; 2017 Aug; 15(4):479-486. PubMed ID: 28040424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.